|
1.
|
Oakes ND, Camilleri S, Furler SM, Chisholm
DJ and Kraegen EW: The insulin sensitizer, BRL 49653, reduces
systemic fatty acid supply and utilization and tissue lipid
availability in the rat. Metabolism. 46:935–942. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Michalik L, Desvergne B and Wahli W:
Peroxisome-proliferator-activated receptors and cancers: complex
stories. Nat Rev Cancer. 4:61–70. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Koeffler HP: Peroxisome
proliferator-activated receptor gamma and cancers. Clin Cancer Res.
9:1–9. 2003.PubMed/NCBI
|
|
4.
|
Castrillo A, Diaz-Guerra M, Hortelano S,
Martin-Sanz P and Bosca L: Inhibition of IκB kinase and IκB
phosphorylation by 15-deoxyΔ12–14-prostaglandin
J2 in activated murine macrophages. Mol Cel Biol.
20:1692–1698. 2000.
|
|
5.
|
Feinstein D, Spagnolo A, Akar C, Weinberg
G, Murphy P, Gavrilyuk V, et al: Receptor-independent actions of
PPAR thiazolidinedione agonists: Is mitochondrial function the key?
Biochem Pharmacol. 2005:177–188. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Wei S, Yang J, Lee SL, Kulp SK and Chen
CS: PPARgamma-independent antitumor effects of thiazolidinediones.
Cancer Lett. 276:119–124. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Niture SK, Kaspar JW, Shen J and Jaiswal
AK: Nrf2 signaling and cell survival. Toxicol Appl Pharmacol.
244:37–42. 2009. View Article : Google Scholar
|
|
8.
|
Gong P, Stewart D, Hu B, Li N, Cook J, Nel
A, et al: Activation of the mouse heme oxygenase-1 gene by
15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress
response elements and transcription factor Nrf2. Antioxid Redox
Signal. 4:249–257. 2002. View Article : Google Scholar
|
|
9.
|
Palakurthi SS, Aktas H, Grubissich LM,
Mortensen RM and Halperin JA: Anticancer effects of
thiazolidinediones are independent of peroxisome
proliferator-activated receptor gamma and mediated by inhibition of
translation initiation. Cancer Res. 61:6213–6218. 2001.PubMed/NCBI
|
|
10.
|
Shiau C, Yang C, Kulp S, Chen K, Chen C,
Huang J, et al: Thiazolidinediones mediate apoptosis in prostate
cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions
independently of PPARγ. Cancer Res. 65:1561–1569. 2005.PubMed/NCBI
|
|
11.
|
Sohda T, Momose Y, Meguro K, Kawamatsu Y,
Sugiyama Y and Ikeda H: Studies on antidiabetic agents. Synthesis
and hypoglycemic activity of
5-[4-(pyridylalkoxy)-benzyl]-2,4-thiazolidinediones. Arzneim
Forsch. 40:37–42. 1990.
|
|
12.
|
Deguest G, Bischoff L, Fruit L and Marsais
F: Anionic, in situ generation of formaldehyde: a very useful and
versatile tool in synthesis. Org Lett. 9:1165–1167. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lenton K, Therriault H and Wagner J:
Analysis of glutathione and glutathione disulfide in whole cells
and mitochondria by postcolumn derivatization high-performance
liquid chromatography with ortho-phthaladehyde. Anal Biochem.
274:125–130. 1999. View Article : Google Scholar
|
|
14.
|
Atarod EB and Kehrer JP: Dissociation of
oxidant production by peroxisome proliferator-activated receptor
ligands from cell death in human cell lines. Free Radic Biol Med.
37:36–47. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Liu M, Wikonkal NM and Brash DE: Induction
of cyclin-dependent kinase inhibitors and G(1) prolongation by the
chemopreventive agent N-acetylcysteine. Carcinogenesis.
20:1869–1872. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Uchida K and Shibata T:
15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic
trigger of cellular responses. Chem Res Toxicol. 21:138–144.
2008.PubMed/NCBI
|
|
17.
|
Kliewer SA: A prostaglandin J2
metabolite binds peroxisome proliferator-activated receptor gamma
and promotes adipocyte differentiation. Cell. 83:813–819.
1995.PubMed/NCBI
|
|
18.
|
Shimada T, Kojima K, Yoshiura K, Hiraishi
H and Terano A: Characteristics of the peroxisome proliferator
activated receptor gamma (PPARgamma) ligand induced apoptosis in
colon cancer cells. Gut. 50:658–664. 2002. View Article : Google Scholar
|
|
19.
|
Levonen AL, Dickinson DA, Moellering DR,
Mulcahy RT, Forman HJ and Darley-Usmar VM: Biphasic effects of
15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction
and apoptosis in human endothelial cells. Arterioscler Thromb Vasc
Biol. 21:1846–1851. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Polvani S, Tarocchi M and Galli A:
PPARgamma and oxidative stress: Con(beta) catenating NRF2 and FOXO.
PPAR Res. 2012:6410872012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Schaefer KL, Takahashi H, Morales VM,
Harris G, Barton S, Osawa E, et al: PPARgamma inhibitors reduce
tubulin protein levels by a PPARgamma, PPARdelta and
proteasome-independent mechanism, resulting in cell cycle arrest,
apoptosis and reduced metastasis of colorectal carcinoma cells. Int
J Cancer. 120:702–713. 2007. View Article : Google Scholar
|
|
22.
|
Mueller E, Sarraf P, Tontonoz P, Evans RM,
Martin KJ, Fletcher M, et al: Terminal differentiation of human
breast cancer through PPARγ. Mol Cell. 1:465–470. 1998.
|
|
23.
|
Cerquetti L, Sampaoli C, Amendola D, Bucci
B, Masuelli L, Marchese R, et al: Rosiglitazone induces autophagy
in H295R and cell cycle deregulation in SW13 adrenocortical cancer
cells. Exp Cell Res. 317:1397–1410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Zhou J, Zhang W, Liang B, Casimiro MC,
Whitaker-Menezes D, Wang M, et al: PPARgamma activation induces
autophagy in breast cancer cells. Int J Biochem Cell Biol.
41:2334–2342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Rodway HA, Hunt AN, Kohler JA, Postle AD
and Lillycrop KA: Lysophosphatidic acid attenuates the cytotoxic
effects and degree of peroxisome proliferator-activated receptor
gamma activation induced by
15-deoxyDelta12,14-prostaglandin J2 in
neuroblastoma cells. Biochem J. 382:83–91. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Rao VA, Klein SR, Bonar SJ, Zielonka J,
Mizuno N, Dickey JS, et al: The antioxidant transcription factor
Nrf2 negatively regulates autophagy and growth arrest induced by
the anticancer redox agent mitoquinone. J Biol Chem.
285:34447–34459. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Perez-Ortiz JM, Tranque P, Burgos M,
Vaquero CF and Llopis J: Glitazones induce astroglioma cell death
by releasing reactive oxygen species from mitochondria: modulation
of cytotoxicity by nitric oxide. Mol Pharmacol. 72:407–417. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Kondo M, Oya-Ito T, Kumagai T, Osawa T and
Uchida K: Cyclopentone prostaglandins as potential inducers of
intracellular oxidative stress. J Biol Chem. 276:12076–12083. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Ghosh S, Patel N, Rahn D, McAllister J,
Sadeghi S, Horwitz G, et al: The thiazolidinedione pioglitazone
alters mitochondrial function in human neuron-like cells. Mol
Pharmacol. 71:1695–1702. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Brunoldi EM, Zanoni G, Vidari G, Sasi S,
Freeman ML, Milne GL, et al: Cyclopentenone prostaglandin,
15-deoxy-Delta12,14-PGJ2, is metabolized by
HepG2 cells via conjugation with glutathione. Chem Res Toxicol.
20:1528–1535. 2007.PubMed/NCBI
|
|
31.
|
Wu G, Fang YZ, Yang S, Lupton JR and
Turner ND: Glutathione metabolism and its implications for health.
J Nutr. 134:489–492. 2004.PubMed/NCBI
|
|
32.
|
Alvarez-Sanchez R, Montavon F, Hartung T
and Pähler A: Thazolididedione bioactivation: a comparison of the
bioactivation potentials of troglitazone, rosiglitazone, and
pioglitazone using stable isotope-labeled analogues and liquid
chromatography tandem mass spectrophometry. Chem Res Toxicol.
16:1106–1116. 2006. View Article : Google Scholar
|
|
33.
|
Uchiyama M, Fischer T, Mueller J, Oguchi
M, Yamamura N, Koda H, et al: Identification of novel metabolic
pathways of pioglitazone in hepatocytes: N-glucuronidation of
thiazolidinedione ring and sequential ring-opening pathway. Drug
Metab Dispos. 38:946–956. 2010. View Article : Google Scholar
|
|
34.
|
Ferguson HE, Thatcher TH, Olsen KC,
Garcia-Bates TM, Baglole CJ, Kottmann RM, et al: Peroxisome
proliferator-activated receptor-gamma ligands induce heme
oxygenase-1 in lung fibroblasts by a PPARgamma-independent,
glutathione-dependent mechanism. Am J Physiol Lung Cell Mol
Physiol. 297:L912–L919. 2009. View Article : Google Scholar
|
|
35.
|
Li CQ, Kim MY, Godoy LC, Thiantanawat A,
Trudel LJ and Wogan GN: Nitric oxide activation of Keap1/Nrf2
signaling in human colon carcinoma cells. Proc Natl Acad Sci USA.
106:14547–14551. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Chia AJ, Goldring CE, Kitteringham NR,
Wong SQ, Morgan P and Park BK: Differential effect of covalent
protein modification and glutathione depletion on the
transcriptional response of Nrf2 and NF-kappaB. Biochem Pharmacol.
80:410–421. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Kronke G, Kadl A, Ikonomu E, Bluml S,
Furnkranz A, Sarembock IJ, et al: Expression of heme oxygenase-1 in
human vascular cells is regulated by peroxisome
proliferator-activated receptors. Arterioscler Thromb Vasc Biol.
27:1276–1282. 2007. View Article : Google Scholar : PubMed/NCBI
|
